Results 121 to 130 of about 3,746,167 (305)

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Immersive mixed-reality configuration of hybrid user interfaces

, 2005
Information in hybrid user interfaces can be spread over a variety of different, but complementary, displays, with which users interact through a potentially equally varied range of interaction devices. Since the exact configuration of these displays and
A. Olwal, Feiner, S., Olwal, Alex,, Sandor, C., S. Feiner, Bell, B., Olwal, A., B. Bell, C. Sandor   +8 more
core   +1 more source

Corticomedullary Mixed Tumor of the Adrenal Gland with Apparent ¹⁸F-Fluorodeoxyglucose Activity But No ⁶⁸GA-DOTATATE Uptake on Positron Emission Tomography/Computed Tomography. [PDF]

Indian J Nucl Med, 2022
Engur CO, Apaydın T, Ones T, Gozu HI, Ozguven S.   +4 more
europepmc   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Comparative analysis of magnetic resonance imaging images of parotid gland mixed tumor and adenolymphoma

肿瘤影像学, 2020
Objective: To improve the diagnostic accuracy between parotid gland mixed tumor and parotid gland adenolymphoma by comparing their features on magnetic resonance imaging (MRI).
LIN Yang, WU Lifang, CHEN Yi
doaj  

Editorial Comment to A case of mixed tumor formed by metastasis of urothelial carcinoma and malignant lymphoma to the same lymph nodes. [PDF]

IJU Case Rep, 2021
Sekito T, Sadahira T.
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Quantitation of rare circulating tumor cells by folate receptor alpha ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance

, 2014
Numerous attempts for detection of circulating tumor cells (CTC) have been made to develop reliable assays for early diagnosis of cancers. In this study, we validated the application of folate receptor alpha (FR alpha) as the tumor marker to detect CTC ...
Li, Feiyang, Cai, Zhiming, Zhou, Fangjian, Zhao, Rongchang, Zou, Xiangjun, Xia, Ye, Zhang, Lei, Qi, Fuming, Liu, Chunxiao, Sun, Xiaojuan, Xing, Li, Liu, Yuchen, Gui, Yaoting, Wang, Xuliang, Wang, Yongqiang, Tang, Junlong, Lu, Jingxiao, Li, Jiaqiang, Zou, Xiaowen, Li, Cailing   +19 more
core   +1 more source

Ultra-small superparamagnetic iron oxide (USPIO) magnetic resonance imaging in benign mixed tumor of the parotid gland. [PDF]

Clin Case Rep, 2021
Johnson JM, Mohamed ASR, Ding Y, Wang J, Lai SY, Fuller CD, Shah R, Butler RT, Weber RS.   +8 more
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source